XML 35 R35.htm IDEA: XBRL DOCUMENT v3.2.0.727
Business Combinations-Merger Between Uroplasty, Inc and Vision-Sciences, Inc (Details) - USD ($)
12 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Business Acquisition [Line Items]    
Reverse stock split ratio 5  
Shares issued for each share of UPI common stock outstanding 0.72662  
Purchase price allocation [Abstract]    
Number of shares of VSCI shares outstanding on March 31, 2015 (after 1:5 reverse stock split) (in shares) 25,676,212 15,734,108
Total purchase price $ 16,500,000  
Assumptions applied in determining the fair value of deemed conversion of VSCI stock options and warrants [Abstract]    
Risk-free interest rate (in hundredths) 1.37%  
Expected volatility (in hundredths) 65.00%  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]    
Goodwill $ 18,749,888 $ 0
Uroplasty Inc [Member]    
Business Acquisition [Line Items]    
Ownership percentage (in hundredths) 62.50%  
Vision- Sciences Inc [Member]    
Business Acquisition [Line Items]    
Reverse stock split ratio 5  
Shares issued for each share of UPI common stock outstanding 0.72662  
Ownership percentage (in hundredths) 37.50%  
Purchase price allocation [Abstract]    
Number of shares of VSCI shares outstanding on March 31, 2015 (after 1:5 reverse stock split) (in shares) 9,589,539  
Deemed conversion ratio 1.376  
UPI shares deemed (for accounting purposes only) issued to VSCI shareholders (in shares) 13,195,206  
UPI closing price on March 31, 2015 ( merger date) (in dollars per share) $ 1.22  
Total fair value of stock consideration $ 16,098,151  
Fair value of deemed (for accounting purposes only) conversion of VSCI stock options 272,000  
Fair value of deemed (for accounting purposes only) conversion of VSCI warrants 98,849  
Total purchase price 16,469,000  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]    
Cash and cash equivalents 2,020,000  
Accounts receivable 4,249,000  
Inventories 4,462,000  
Other current assets 369,000  
Property, plant and equipment 817,000  
Goodwill 18,750,000  
Other intangibles 13,660,000  
Other non-current assets 97,000  
Total assets acquired 44,424,000  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract]    
Accounts payable and other liabilities 5,209,000  
Deferred revenue 176,000  
Convertible debt - related party 22,530,000  
Other non-current liabilities 40,000  
Total liabilities assumed 27,955,000  
Total purchase price 16,469,000  
Recognition of intangible assets [Abstract]    
Other intangibles 13,660,000  
Acquisition related cost incurred 2,200,000  
Supplemental pro forma combined results of operations [Abstract]    
Net sales 44,973,000 41,523,000
Net loss $ (15,817,000) $ (21,477,000)
Loss per share - basic and diluted (in dollars per share) $ (0.62) $ (0.86)
Adjustments to supplemental pro forma combined results of operations [Abstract]    
Increase in amortization of intangibles $ 2,334,000 $ 2,464,000
Adjust expenses related to merger (transaction costs, inventory step-up, deferred revenue adjustment) (4,399,000) 4,801,000
Interest expense imputed on debt 1,198,000 1,144,000
Increase (decrease) in net loss (867,000) $ 8,409,000
Vision- Sciences Inc [Member] | Developed Technology [Member]    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]    
Other intangibles 6,200,000  
Recognition of intangible assets [Abstract]    
Other intangibles $ 6,200,000  
Weighted Average Life-Years 7 years  
Vision- Sciences Inc [Member] | Customer Relationships [Member]    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]    
Other intangibles $ 7,270,000  
Recognition of intangible assets [Abstract]    
Other intangibles $ 7,270,000  
Weighted Average Life-Years 5 years  
Vision- Sciences Inc [Member] | Trade Names [Member]    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]    
Other intangibles $ 190,000  
Recognition of intangible assets [Abstract]    
Other intangibles $ 190,000  
Weighted Average Life-Years 10 years  
Vision- Sciences Inc [Member] | Stock Options [Member]    
Assumptions applied in determining the fair value of deemed conversion of VSCI stock options and warrants [Abstract]    
Expected average term 3 years 9 months  
Vision- Sciences Inc [Member] | Stock Options [Member] | Minimum [Member]    
Assumptions applied in determining the fair value of deemed conversion of VSCI stock options and warrants [Abstract]    
Risk-free interest rate (in hundredths) 0.26%  
Expected volatility (in hundredths) 60.00%  
Vision- Sciences Inc [Member] | Stock Options [Member] | Maximum [Member]    
Assumptions applied in determining the fair value of deemed conversion of VSCI stock options and warrants [Abstract]    
Risk-free interest rate (in hundredths) 1.37%  
Expected volatility (in hundredths) 66.00%  
Vision- Sciences Inc [Member] | Warrant [Member]    
Assumptions applied in determining the fair value of deemed conversion of VSCI stock options and warrants [Abstract]    
Risk-free interest rate (in hundredths) 1.37%  
Expected average term 4 years 6 months  
Expected volatility (in hundredths) 65.00%